Explore innovative treatments for relapsed follicular lymphoma, focusing on novel therapies that enhance patient outcomes and ...
Lunsumio Velo is supplied as a ready-to-use, preservative-free solution in single-dose vials containing 5mg/0.5mL and 45mg/mL.
A groundbreaking study reveals that ultrasensitive ctDNA assays significantly enhance prognosis for large B-cell lymphoma, outperforming traditional PET assessments.
The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...
Sportschosun on MSN
Kang Rae-yeon, I'm in a lot of pain after cancer surgery, and I'm crying. I'm scared
Actor Kang Rae-yeon shared her recent status after cancer surgery.Kang Rae-yeon said on the 2nd that it's a simple surgery, ...
Thyroid cancer stages range from 1 to 4 based on how much the cancer has spread. Papillary thyroid cancer is the most common and has a high five-year survival rate. The TNM staging system is used to ...
Dr Kami Maddocks shares highlights from ASH 2025, including how the phase 3 EPCORE FL‑1 trial, adding a bispecific antibody to R2 in second‑line or later follicular lymphoma, showed significantly ...
Thyroid cancer can spread to the lymph nodes, lungs, bones, liver, brain, and adrenal glands. Early signs of thyroid cancer may include a neck lump, voice changes, and difficulty swallowing.
Background: We aimed to evaluate and compare the efficacies and roles of core-needle biopsy (CNB) and repeat fine-needle aspiration (rFNA) in diagnosing thyroid nodules initially diagnosed as atypia ...
ABSTRACT: Thyroid nodules are a common thyroid condition, with a detection rate of up to 20% - 50% in the general population, of which only 5% - 10% are malignant. Fine-needle aspiration cytology ...
aDepartment of Radiology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China bDepartment of Ultrasound, Guangdong Provincial People's Hospital (Guangdong Academy of Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results